Renaud Buffet

1.9k total citations
19 papers, 1.5k citations indexed

About

Renaud Buffet is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Renaud Buffet has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Renaud Buffet's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Renaud Buffet is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Renaud Buffet collaborates with scholars based in France, United States and Germany. Renaud Buffet's co-authors include Michel Morre, Claude Sportès, Crystal L. Mackall, Ronald E. Gress, Terry J. Fry, Maryalice Stetler‐Stevenson, Michael Krumlauf, Andrew L. Pecora, Robert J. Amato and Catherine K. Chow and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Renaud Buffet

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renaud Buffet France 9 1.0k 530 248 219 172 19 1.5k
F. Ameglio Italy 24 733 0.7× 192 0.4× 270 1.1× 246 1.1× 161 0.9× 65 1.4k
Rima Koka United States 15 1.7k 1.7× 437 0.8× 89 0.4× 300 1.4× 223 1.3× 51 2.1k
Claude Sportès United States 12 818 0.8× 464 0.9× 81 0.3× 139 0.6× 119 0.7× 24 1.1k
Pierre Portalès France 21 671 0.7× 143 0.3× 520 2.1× 256 1.2× 232 1.3× 54 1.3k
Manuela Cota Italy 12 439 0.4× 216 0.4× 310 1.3× 130 0.6× 137 0.8× 15 777
Marie‐Claude Crevon France 18 647 0.6× 197 0.4× 240 1.0× 223 1.0× 129 0.8× 37 1.2k
Emile Foucat France 9 1.1k 1.1× 125 0.2× 148 0.6× 192 0.9× 94 0.5× 13 1.4k
Dawn Jones United States 17 744 0.7× 191 0.4× 171 0.7× 131 0.6× 148 0.9× 28 1.4k
Thérèse Croughs United States 13 667 0.7× 307 0.6× 343 1.4× 228 1.0× 73 0.4× 16 1.1k
Jacques Clot France 20 718 0.7× 103 0.2× 411 1.7× 154 0.7× 112 0.7× 44 1.2k

Countries citing papers authored by Renaud Buffet

Since Specialization
Citations

This map shows the geographic impact of Renaud Buffet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Buffet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Buffet more than expected).

Fields of papers citing papers by Renaud Buffet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud Buffet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Buffet. The network helps show where Renaud Buffet may publish in the future.

Co-authorship network of co-authors of Renaud Buffet

This figure shows the co-authorship network connecting the top 25 collaborators of Renaud Buffet. A scholar is included among the top collaborators of Renaud Buffet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renaud Buffet. Renaud Buffet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Buffet, Renaud, et al.. (2020). The economic burden ofClostridioides difficileinfection in patients with hematological malignancies in the United States: A case-control study. Infection Control and Hospital Epidemiology. 41(7). 813–819. 4 indexed citations
4.
Gunzburg, Jean de, et al.. (2020). NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. 15(7). 1147–1159. 112 indexed citations
5.
6.
Morel, Ariane, Cécile Bonnafous, Sylvia Trichard, et al.. (2016). Abstract 1491: IPH4301, an antibody targeting MICA and MICB exhibits potent cytotoxic activity and immunomodulatory properties for the treatment of cancer. Cancer Research. 76(14_Supplement). 1491–1491. 3 indexed citations
7.
Vey, Norbert, Anthony Gonçalvès, Lionel Karlin, et al.. (2015). A phase 1 dose-escalation study of IPH2102 (lirilumab, BMS-986015, LIRI), a fully human anti KIR monoclonal antibody (mAb) in patients (pts) with various hematologic (HEM) or solid malignancies (SOL).. Journal of Clinical Oncology. 33(15_suppl). 3065–3065. 15 indexed citations
8.
Vey, Norbert, Jean Bourhis, Christian Récher, et al.. (2013). Repeated Dosing Of Anti-KIR (IPH2101) As Maintenance Therapy In Ederly Patients With Acute Myeloid Leukemia. Blood. 122(21). 2696–2696. 6 indexed citations
9.
Vey, Norbert, Hervé Dombret, Norbert Ifrah, et al.. (2013). Intergroup ALFA/GOELAMS randomized phase II trial of lirilumab anti-KIR monoclonal antibody (IPH2102/BMS986015) as maintenance treatment in elderly patients with acute myeloid leukemia (EFFIKIR trial).. Journal of Clinical Oncology. 31(15_suppl). TPS3117–TPS3117. 3 indexed citations
10.
Sportès, Claude, Rebecca Babb, Michael Krumlauf, et al.. (2010). Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy. Clinical Cancer Research. 16(2). 727–735. 170 indexed citations
11.
Sereti, Irini, Richard M. Dunham, John Spritzler, et al.. (2009). IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection. Blood. 113(25). 6304–6314. 263 indexed citations
12.
Sportès, Claude, Frances T. Hakim, Sarfraz Memon, et al.. (2008). Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. The Journal of Experimental Medicine. 205(7). 1701–1714. 375 indexed citations
13.
Rosenberg, Steven A., Claude Sportès, Mojgan Ahmadzadeh, et al.. (2006). IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells. Journal of Immunotherapy. 29(3). 313–319. 346 indexed citations
14.
Cavazzana, Marina, Isabelle André‐Schmutz, Salima Hacein‐Bey, et al.. (2001). Greffe de moelle osseuse T déplétée HLA non géno-identique chez l’enfant : prévention de la réaction du greffon contre l’hôte par adjonction de lymphocytes T du donneur dépourvus d’alloréactivité vis-à-vis du receveur. Journal de la Société de Biologie. 195(1). 65–68. 3 indexed citations
15.
Martin, X., et al.. (2000). Protective effect of an Anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation. Transplantation Proceedings. 32(2). 481–481. 15 indexed citations
16.
Martin, X., Aoumeur Hadj‐Aïssa, Renaud Buffet, et al.. (1997). Autotransplantation of the kidney in primates: A model of renal damage to study the ischemia-reperfusion injury. Transplantation Proceedings. 29(8). 3428–3429. 1 indexed citations
17.
Hourmant, Maryvonne, J Bedrossian, Yvon Lebranchu, et al.. (1996). A RANDOMIZED MULTICENTER TRIAL COMPARING LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 MONOCLONAL ANTIBODY WITH RABBIT ANTITHYMOCYTE GLOBULIN AS INDUCTION TREATMENT IN FIRST KIDNEY TRANSPLANTATIONS. Transplantation. 62(11). 1565–1570. 103 indexed citations
18.
Buffet, Renaud, Christine Katlama, Françis Bolgert, et al.. (1991). Virological markers in the cerebrospinal fluid from HIV-1-infected individuals. AIDS. 5(12). 1419–1424. 24 indexed citations
19.
Mirand, E. A., Nils Bäck, J. T. Grace, & Renaud Buffet. (1967). Effect of Pituitary and Gonadal Hormones on Friend Virus Disease in Mice.. Experimental Biology and Medicine. 124(4). 1055–1059. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Ameglio Breakdown of academic impact, for papers by Rima Koka Breakdown of academic impact, for papers by Claude Sportès Breakdown of academic impact, for papers by Pierre Portalès Breakdown of academic impact, for papers by Manuela Cota Breakdown of academic impact, for papers by Marie‐Claude Crevon Breakdown of academic impact, for papers by Emile Foucat Breakdown of academic impact, for papers by Dawn Jones Breakdown of academic impact, for papers by Thérèse Croughs Breakdown of academic impact, for papers by Jacques Clot
Rankless by CCL
2026